Yellow fever vaccine is the top Russian export product

| By | Export of Medicines, Pharmaceutical Industry, Stada, Vaccines

In January – October, 2017, the Russian exports of medicinal products (excluding exports to EAEU) amounted to 16.7 billion rubles (including customs duties).

In ruble-denominated terms, the export dynamics was negative compared to the same period of the previous year (-2.2%). At the same time, the physical volume of supplies increased by 5.4% (in packages); overall in that period, 465.6 million packages of medicinal products were exported from Russia. The range of exported medicines also expanded significantly. In the first 10 months of this year, foreign recipients purchased the products of about 3190 various brands.

Moreover, the exports from Russia include not only locally manufactured products. In January-October 2017, the medicinal products manufactured in Russia accounted for 64% of total exports in monetary terms and, over the past year, this share increased by 1%. In terms of export volumes, the second rank is held by medicinal products manufactured and previously imported to Russia from Germany (5.5%), and the third rank is held by the companies from Belarus (4.0%).

Among specific medicines, the absolute leader of export volumes is the yellow fever vaccine. Since the beginning of this year, M.P. Chumakov Federal Scientific Center for Research and Development of Immunobiological Products supplied it in amount of almost 1.3 billion rubles. The company supplies the medicine under a program of United Nations Children’s Fund (UNICEF). This year, the shipments were made to 38 countries, with the bulk going to Nigeria, Angola, and Congo.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.